Literature DB >> 8333771

Measles encephalitis during immunosuppressive treatment for acute lymphoblastic leukaemia.

I Hughes1, M E Jenney, R W Newton, D J Morris, P E Klapper.   

Abstract

Between 1971 and 1989 measles encephalitis was identified in five children receiving chemotherapy for acute lymphoblastic leukaemia. Review of these and previously reported cases of measles encephalitis in immunosuppressed patients failed to identify any pathognomonic features in the history, the clinical presentation, or the results of electroencephalography or computed tomography. Detection of measles virus antigen in nasopharyngeal secretions or intrathecal synthesis of specific antibody was not possible in all instances. Early diagnosis by direct detection of viral antigen in the brain was confounded by difficulties in identifying areas of the brain suitable for biopsy. Increasing herd immunity to measles in the general population by vaccination is the only effective intervention against measles encephalitis in immunosuppressed children. Measles encephalitis must be remembered as a possible explanation of encephalopathy in the immunocompromised child: the benefits of early use of antiviral agents need to be evaluated.

Entities:  

Mesh:

Year:  1993        PMID: 8333771      PMCID: PMC1029373          DOI: 10.1136/adc.68.6.775

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  21 in total

1.  Measles in children who have malignant disease.

Authors:  J Kernahan; J McQuillin; A W Craft
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-04

2.  Fatal measles encephalopathy with retinopathy during cytotoxic chemotherapy.

Authors:  M Haltia; A Paetau; A Vaheri; H Erkkilä; M Donner; K Kaakinen; T Holmström
Journal:  J Neurol Sci       Date:  1977-07       Impact factor: 3.181

3.  Fatal measles infection in children with leukemia.

Authors:  V Breitfeld; Y Hashida; F E Sherman; K Odagiri; E J Yunis
Journal:  Lab Invest       Date:  1973-03       Impact factor: 5.662

4.  Letter: Atypical measles encephalitis in leukaemic children in remission.

Authors:  D Smyth; J H Tripp; E M Brett; W C Marshall; J Almeida; A D Dayan; J C Coleman; R Dayton
Journal:  Lancet       Date:  1976-09-11       Impact factor: 79.321

5.  Immunosuppressive measles encephalopathy.

Authors:  F K Pedersen; P O Schiøtz; N H Valerius; H Hertz
Journal:  Acta Paediatr Scand       Date:  1978-01

6.  Measles inclusion-body encephalitis in a child with treated acute lymphoblastic leukaemia.

Authors:  H C Drysdale; L F Jones; D R Oppenheimer; A H Tomlinson
Journal:  J Clin Pathol       Date:  1976-10       Impact factor: 3.411

7.  Measles encephalopathy during immunosuppression: failure of interferon treatment.

Authors:  E Olding-Stenkvist; M Forsgren; D Henley; A Kreuger; K M Lundmark; A Nilsson; G Wadell
Journal:  Scand J Infect Dis       Date:  1982

8.  Unusual encephalitic illnesses in a child with acute leukaemia in remission: possible role of measles virus and Toxoplasma gondii.

Authors:  D H Mellor; M Purcell
Journal:  Neuropadiatrie       Date:  1976-11

9.  Serious infections during continuing treatment of acute lymphoblastic leukaemia.

Authors:  J Ninane; J M Chessells
Journal:  Arch Dis Child       Date:  1981-11       Impact factor: 3.791

10.  Acute measles encephalitis in children with immunosuppression.

Authors:  J Aicardi; F Goutieres; M L Arsenio-Nunes; P Lebon
Journal:  Pediatrics       Date:  1977-02       Impact factor: 7.124

View more
  5 in total

1.  Brain endothelial cell infection in children with acute fatal measles.

Authors:  L M Esolen; K Takahashi; R T Johnson; A Vaisberg; T R Moench; S L Wesselingh; D E Griffin
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

2.  Immunoglobulin G avidity testing in serum and cerebrospinal fluid for analysis of measles virus infection.

Authors:  M Narita; S Yamada; Y Matsuzono; O Itakura; T Togashi; H Kikuta
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

3.  Measles Virus Bearing Measles Inclusion Body Encephalitis-Derived Fusion Protein Is Pathogenic after Infection via the Respiratory Route.

Authors:  Cyrille Mathieu; Marion Ferren; Eric Jurgens; Claire Dumont; Ksenia Rybkina; Olivia Harder; Debora Stelitano; Silvia Madeddu; Giuseppina Sanna; Dayna Schwartz; Sudipta Biswas; Diana Hardie; Takao Hashiguchi; Anne Moscona; Branka Horvat; Stefan Niewiesk; Matteo Porotto
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

Review 4.  Measles Encephalitis: Towards New Therapeutics.

Authors:  Marion Ferren; Branka Horvat; Cyrille Mathieu
Journal:  Viruses       Date:  2019-11-02       Impact factor: 5.048

5.  Molecular Features of the Measles Virus Viral Fusion Complex That Favor Infection and Spread in the Brain.

Authors:  Cyrille Mathieu; Francesca T Bovier; Marion Ferren; Nicole A P Lieberman; Camilla Predella; Alexandre Lalande; Vikas Peddu; Michelle J Lin; Amin Addetia; Achchhe Patel; Victor Outlaw; Barbara Corneo; N Valerio Dorrello; Thomas Briese; Diana Hardie; Branka Horvat; Anne Moscona; Alexander L Greninger; Matteo Porotto
Journal:  mBio       Date:  2021-06-01       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.